Trials Sponsors Conditions Drugs Pricing

Conditions

Keywords

Document the number, type, and severity of DRPsin HD patients.Determine the rates and categorization ofDRPs-associated hospitalizations in HD patients.Document the number and types of pharmaceuticalCare Interventions.Determine the outcomes of pharmaceutical careInterventionDetermine the rate of acceptance of pharmaceuticalCare Interventions .Assign significance rank to pharmaceuticalDetermine annual drug cost in HD patients.Determine drug cost associated for treatmentof each HD patient comorbidity.Determine Quality of Life (QoL) using a renal-specific instrument

Outcome Measures

Primary Outcomes (1)

Reduction in at home medications
Behavioral: Patent care
through study completion, an average of 1 year

Study Arms (1)

Behavioral Patient Care

NO INTERVENTION

Chart review

Other: Behavioral Patient care

Interventions

Behavioral Patient careOther

chart review

Also known as: Chart review

Behavioral Patient Care

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

Patients will be excluded if they have been on HD for less than three months, decline the opportunity to participate, or are less than 18 years of age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

University of New Mexico
Otherlead

MeSH Terms

Conditions

Kidney Failure, ChronicLimb-girdle muscular dystrophy, type 2C

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

Amy B Pai, Pharm.D
University of New Mexico
PRINCIPAL INVESTIGATOR

Enrollment

0 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: NONE
Purpose: HEALTH SERVICES RESEARCH
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

July 9, 2008

First Posted

July 19, 2023

Study Start

January 2003

Actual (reported)

Study Stopped

Impact of Clinical Pharmacy Services on Medication Cost and Hospitalization Rates in Hemodialysis Patients

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Behavioral Patient Care

Interventions

Eligibility Criteria

You may not qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Behavioral Patient Care

Interventions

Eligibility Criteria

You may not qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record